Anxiety disorders rank among the most prevalent mental health conditions, yet classical anxiolytics (benzodiazepines) frequently carry a trail of undesirable effects: daytime drowsiness, muscle relaxation, impaired concentration, and a high risk of dependence. Selank 0.15% is an original Russian neuropeptide drug, created at the intersection of neurochemistry and molecular pharmacology. It exerts an anxiolytic (anti-anxiety) effect comparable to that of benzodiazepines but is devoid of their drawbacks — causing no sedation, no muscle relaxation, no habituation, and no withdrawal syndrome. The formulation — sterile nasal drops — provides direct, rapid peptide transport to the brain along the olfactory nerve, bypassing the blood-brain barrier.
Selank is the synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro. Structurally, it is a modified analogue of tuftsin — a natural immunomodulatory peptide derived from the IgG heavy chain. It is the addition of the Pro-Gly-Pro sequence to the C-terminus of the tuftsin molecule that transforms it from an immunomodulator into a potent anxiolytic with a unique profile.
The mechanism of action of Selank is multifaceted and contrasts favorably with that of classical tranquilizers:
1. Modulation of the GABA-Ergic System.
Unlike benzodiazepines, which bind directly to GABA-A receptors and "forcibly" enhance their function, Selank operates more subtly. It upregulates the expression of genes encoding GABA receptors and increases the density of benzodiazepine-binding sites upon them. The result is a natural, physiological enhancement of inhibitory neurotransmission — without the risk of overdose, respiratory depression, or tolerance development.2. Influence on the Dopamine and Noradrenergic Systems.
Selank normalizes the turnover of dopamine and noradrenaline in the limbic system and prefrontal cortex, correcting the imbalance that underlies anxiety and asthenic-depressive states. This explains the paradoxical combination: the drug quells anxiety while not reducing — and potentially even enhancing — motivation and mental clarity.3. Nootropic Component.
Selank boosts the production of brain-derived neurotrophic factor (BDNF), improves synaptic plasticity, and facilitates the formation of memory engrams. It does more than simply eliminate anxiety — it helps the brain adapt to stress and recover from it.4. Antiviral and Immunomodulatory Activity.
Owing to its kinship with tuftsin, Selank retains the ability to activate natural killer cells and macrophages, rendering it particularly valuable during periods of heightened infectious burden and for patients with immunodeficiency conditions.Selank 0.15% is deployed in psychiatric, neurological, and general medical practice:
1. Anxiety and Anxiety-Depressive Disorders:
2. Asthenic States:
3. Adjustment Disorders:
4. Neurological Pathology:
Selank 0.15% is a clear, colorless solution supplied in a dropper bottle or metered-dose device. The drops are instilled into the nasal passages onto cleansed mucosa.
Instillation Technique:
Selank is not prescribed in the setting of:
Selank is distinguished by an exceptionally favorable safety profile. Over the entire period of clinical use, not a single case of overdose, drug dependence, or withdrawal syndrome has been registered.
The bottle must be stored in a light-protected location at a temperature of 2–10 °C (36–50 °F) — in a refrigerator. Once opened, the contents must be used within 30 days. Keep out of the reach of children.
The photograph is provided for product identification. Packaging design may vary by batch or market. This page provides general product information and does not replace the package leaflet, diagnosis, prescription or advice from a doctor or pharmacist.

